Ottawa based, Marcan Pharmaceuticals Inc. is a rapidly growing pharmaceutical company actively engaged in the development, marketing, sales and distribution of both brand and generic pharmaceutical products for the Canadian market.
Marcan currently manufactures and distributes a variety of medications covering a wide array of therapeutic categories through numerous dosage forms.
In 2015, Marcan was acquired by Emcure Pharmaceuticals LTD., a vertically integrated global manufacturer and R&D leader. Through optimizing this partnership, Marcan continues to focus on the development and growth of its Canadian portfolio.
IPG- Product development arm of our company founded
Launched 1st Rx product for licensing
Launched 1st first-to-market generic.
Established Marcan Pharmaceuticals Inc. the sales, marketing and distribution arm of the company
Marcan/IPG acquired by Emcure Pharmaceuticals
Launched first alternative dosage product in the form of an injectable.
Continued development of hospital focused portfolio.
Our mission is to be a leader in supplying innovative, high quality and cost-effective medications to Canadians.
We work closely with organizations engaged in generics related research and development (R&D) as well as decision-makers at grassroots like pharmacy chains to sell quality generics in Canada.